Search for Clinical Trial Results

Sponsored By

Long QT Syndrome - 31 Studies Found

Status Study
Recruiting Study Name: Long QT Syndrome Screening in Newborns
Condition: Long QT Syndrome
Date: 2015-04-01
Interventions: Device: QTScreen ECG Recorder Subjects will be randomly assigned to the: Parents Performing ECG (PPE) gr
Recruiting Study Name: The Canadian National Long QT Syndrome Registry
Condition: Long QT Syndrome
Date: 2014-11-13
Recruiting Study Name: Prospective Identification of Long QT Syndrome in Fetal Life
Condition: Long QT Syndrome
Date: 2016-08-08
Recruiting Study Name: Multicenter Evaluation of Children and Young Adults With Genotype Positive Long QT Syndrome
Condition: Long QT Syndrome
Date: 2012-10-04
Not yet recruiting Study Name: Effect of Grapefruit on QT Interval in Healthy Volunteers and Patients With Congenital Long QT Syndrome
Condition: Long QT Syndrome
Date: 2016-01-28
Interventions:
  • Drug: Moxifloxacin a single 40
Terminated Study Name: Effect of Eleclazine on Shortening of the QT Interval, Safety, and Tolerability in Adults With Long QT Syndrome Type 3
Condition: Long QT Syndrome Type 3
Date: 2014-11-21
Interventions:
  • Drug: Eleclazine Eleclazine ta
Recruiting Study Name: Abnormal QT-Response to the Sudden Tachycardia Provoked by Standing in Individuals With Drug-induced Long QT Syndrome
Condition: Long QT Syndrome
Date: 2015-10-08
Interventions: Device: tilt table Participating individuals will be instr
Completed Study Name: Effect of Oral GS-6615 on Dofetilide-Induced QT Prolongation, Safety, and Tolerability in Healthy Adults
Condition: Long QT Syndrome
Date: 2015-02-13
Interventions:
  • Drug: GS-6615 GS-6615 tablets

Recruiting Study Name: Long Term Prophylactic Therapy of Congenital Long QT Syndrome Type III (LQT3) With Ranolazine
Condition: Long QT Syndrome Type 3
Date: 2012-11-12
Interventions: Drug: Ranolazine Other Name: Ranexa
Completed Study Name: Study of the Effect of GS-6615 in Subjects With LQT-3
Condition: Long QT Syndrome
Date: 2013-05-06
Interventions: Drug: GS-6615 GS-6615 tablet(s) administered orally
Next >>>